Delivery Order SPE2DB25D7056-SPE2DB25FTMWS
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,892.00 delivery order to AmerisourceBergen Drug Corp for Jolessa 0.15 mg–0.03 mg tablets (91-count supply) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.03, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is not a set-aside and is a firm fixed-price delivery order, with a performance period through May 2, 2025. AmerisourceBergen Drug Corp, based in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $237.23 to Amerisourcebergen Drug Corporation for the supply of 4561522540 JOLESSA 0.15 MG-0.03 MG TABLET 91S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania within the period of performance between July 17-18, 2023. The Defense Logistics Agency utilizes numerous contracts to support the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of Jolessa 0.15 mg-0.03 mg tablets. The contract is a firm fixed price delivery order with a ceiling value of $1,019.54 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is providing these pharmaceutical products to support military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,853.46 and a period of performance through March 12, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by...
- This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,334.60, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 1, 2023. The contract is not designated as a set-aside award. AmerisourceBergen holds a...